Hybrid fertility and reproductive care firm Kindbody scored a $25 million funding from JPMorgan Chase’s enterprise unit specializing in employer-sponsored healthcare, Morgan Well being.
Dr. Cheryl Pegus, managing director of Morgan Well being Ventures, will be part of Kindbody’s board of administrators.
WHAT THEY DO
The New York-based firm presents digital and in-person providers, together with egg freezing, contraception care, gynecological care, fertility testing, and digital wellness and training providers.
Kindbody touts itself as a fertility advantages platform for 112 firms, together with Walmart, Lyft and GEICO.
The funds can be used to scale the supply of its platform.
„The limitations related to fertility make beginning or rising a household tough for thousands and thousands of People. Kindbody’s mission to supply a brand new fertility expertise with their very own healthcare professionals and advantages navigation is exclusive. Their deal with bettering entry and well being outcomes helps mitigate most of the longstanding fairness challenges employers and staff face,“ Dr. Pegus stated in a press release. „I look ahead to becoming a member of the Kindbody Board and dealing with the management staff to satisfy the well being wants for the communities Kindbody serves.“
MARKET SNAPSHOT
Simply two months in the past, Kindbody scored a whopping $100 million in funding.
In 2021, it raised $62 million in Sequence C funding, which constructed on a $32 million Sequence B increase from July 2020.
Final 12 months, the corporate made three acquisitions: genomics firm Phosphorus Labs, a community of fertility clinics referred to as the Vios Fertility Institute and Chicago-based surrogacy company Different Reproductive Assets.
Different firms within the fertility house embody fertility testing firm Proov, reproductive advantages supervisor Carrot Fertility and Nodal, a platform permitting surrogates to attach with meant mother and father after reviewing their guardian profiles.
